COVID-19 and the Biophotonics Industry

Tom Hausken

Even the biophotonics industry took a hit in 2020, although pandemic-related revenues point toward growth in 2021.

Log in or become a member to view the full text of this article.

This article may be available for purchase via the search at Optica Publishing Group.
Optica Members get the full text of Optics & Photonics News, plus a variety of other member benefits.

Publish Date: 01 April 2021

Add a Comment